2018 EHRA/HRS/APHRS/LAHRS专家共识:心律失常和认知功能

2018-03-18 欧洲心律学会 Heart Rhythm 2018:e1–e24.

2018年欧洲心律学会(EHRA)、心律协会(HRS)、亚太心律学会(APHRS)以及拉丁美洲心率学会(LAHRS)共同发布了心律失常和认知功能的专家共识。文章内容基于来自多个国家的专家观点和证据,建议内容百科房颤患者认识功能障碍的预防。

中文标题:

2018 EHRA/HRS/APHRS/LAHRS专家共识:心律失常和认知功能

英文标题:

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function

发布机构:

欧洲心律学会

发布日期:

2018-03-18

简要介绍:

2018年欧洲心律学会(EHRA)、心律协会(HRS)、亚太心律学会(APHRS)以及拉丁美洲心率学会(LAHRS)共同发布了心律失常和认知功能的专家共识。文章内容基于来自多个国家的专家观点和证据,建议内容百科房颤患者认识功能障碍的预防。

 

拓展指南:心律失常相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2018 EHRA/HRS/APHRS/LAHRS专家共识:心律失常和认知功能)] GetToolGuiderByIdResponse(projectId=1, id=344f71c0015699ab, title=2018 EHRA/HRS/APHRS/LAHRS专家共识:心律失常和认知功能, enTitle=European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function, guiderFrom=Heart Rhythm 2018:e1–e24., authorId=null, author=, summary=2018年欧洲心律学会(EHRA)、心律协会(HRS)、亚太心律学会(APHRS)以及拉丁美洲心率学会(LAHRS)共同发布了心律失常和认知功能的专家共识。文章内容基于来自多个国家的专家观点和证据,建议内容百科房颤患者认识功能障碍的预防。 , cover=, journalId=null, articlesId=null, associationId=206, associationName=欧洲心律学会, associationIntro=欧洲心律学会(EHRAE,uropean Heart Rhythm Association)是欧洲心脏病学会的分支,致力于心律失常的预防与管理,以减少心律失常对患者的影响,减少心源性猝死。官方杂志《欧洲心律失常杂志》影响因子为1.839, copyright=0, guiderPublishedTime=Sun Mar 18 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年欧洲心律学会(EHRA)、心律协会(HRS)、亚太心律学会(APHRS)以及拉丁美洲心率学会(LAHRS)共同发布了心律失常和认知功能的专家共识。文章内容基于来自多个国家的专家观点和证据,建议内容百科房颤患者认识功能障碍的预防。 </P> <P> </P>拓展指南:<strong>与<font color=red>心律失常</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=2c8a51c001561ab6" title="2017 AHA/ACC/HRS室性心律失常处理与预防心脏猝死指南释要" target=_blank>2017 AHA/ACC/HRS室性心律失常处理与预防心脏猝死指南释要</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=570771c0015590ff" title="2018 EHRA/ESC共识:抗心律失常药物的临床用药及临床决策制定" target=_blank>2018 EHRA/ESC共识:抗心律失常药物的临床用药及临床决策制定</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=2c5a71c001555576" title="中国儿童心律失常导管消融专家共识解读" target=_blank>中国儿童心律失常导管消融专家共识解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=85ae41c0015a55a1" title="中国儿童心律失常导管消融专家共识" target=_blank>中国儿童心律失常导管消融专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3e0311c001515525" title="2017 AHA/ACC/HRS指南:室性心律失常的管理和心脏性猝死的预防" target=_blank>2017 AHA/ACC/HRS指南:室性心律失常的管理和心脏性猝死的预防</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%BE%8B%E5%A4%B1%E5%B8%B8" target=_blank>有关心律失常更多指南</a></ul>, tagList=[TagDto(tagId=318, tagName=心律失常), TagDto(tagId=3907, tagName=认知功能)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=6405, appHits=293, showAppHits=0, pcHits=4957, showPcHits=1811, likes=137, shares=8, comments=16, approvalStatus=1, publishedTime=Wed Mar 21 22:38:20 CST 2018, publishedTimeString=2018-03-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Wed Mar 21 22:38:20 CST 2018, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 23:11:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2018 EHRA/HRS/APHRS/LAHRS专家共识:心律失常和认知功能)])
2018 EHRA/HRS/APHRS/LAHRS专家共识:心律失常和认知功能
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=299490, encodeId=ad2e299490ac, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:21 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299489, encodeId=5f74299489ae, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:15 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299488, encodeId=2f422994883e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:09 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299487, encodeId=64dd29948e1e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:03 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299486, encodeId=24a8299486bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:58:58 CST 2018, time=2018-03-25, status=1, ipAttribution=)]
    2018-03-25 Y—xianghai

    学习了新知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=299490, encodeId=ad2e299490ac, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:21 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299489, encodeId=5f74299489ae, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:15 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299488, encodeId=2f422994883e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:09 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299487, encodeId=64dd29948e1e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:03 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299486, encodeId=24a8299486bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:58:58 CST 2018, time=2018-03-25, status=1, ipAttribution=)]
    2018-03-25 Y—xianghai

    学习了新知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=299490, encodeId=ad2e299490ac, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:21 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299489, encodeId=5f74299489ae, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:15 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299488, encodeId=2f422994883e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:09 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299487, encodeId=64dd29948e1e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:03 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299486, encodeId=24a8299486bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:58:58 CST 2018, time=2018-03-25, status=1, ipAttribution=)]
    2018-03-25 Y—xianghai

    学习了新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=299490, encodeId=ad2e299490ac, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:21 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299489, encodeId=5f74299489ae, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:15 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299488, encodeId=2f422994883e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:09 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299487, encodeId=64dd29948e1e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:03 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299486, encodeId=24a8299486bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:58:58 CST 2018, time=2018-03-25, status=1, ipAttribution=)]
    2018-03-25 Y—xianghai

    学习了新知识

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=299490, encodeId=ad2e299490ac, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:21 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299489, encodeId=5f74299489ae, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:15 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299488, encodeId=2f422994883e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:09 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299487, encodeId=64dd29948e1e, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:59:03 CST 2018, time=2018-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=299486, encodeId=24a8299486bc, content=学习了新知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201006/4db877c2887649beb09cb5effd0b38c7/916f66edd48a4e77b20ebc3e14b6e45c.jpg, createdBy=141e1980133, createdName=Y—xianghai, createdTime=Sun Mar 25 08:58:58 CST 2018, time=2018-03-25, status=1, ipAttribution=)]
    2018-03-25 Y—xianghai

    学习了新知识

    0